Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:
2025 Wells Fargo Healthcare ConferenceSeptember 3, 202510:15 AM EDT
Baird 2025 Global Healthcare ConferenceSeptember 9, 20259:05 AM EDT
Morgan Stanley 23rd Annual Global Healthcare ConferenceSeptember 10, 202510:45 AM EDT
A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visithttps://www.bio-techne.comor follow the Company on social media at:LinkedIn, XorYouTube.
Contact: David Clair, Vice President, Investor Relations & Corporate Development david.clair@bio-techne.com
https://mma.prnewswire.com/media/2470019/Bio_Techne_Corporation__logo.jpg
https://c212.net/c/img/favicon.png?sn=CG59580&sd=2025-08-27
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302539292.html
SOURCE Bio-Techne Corporation
https://rt.newswire.ca/rt.gif?NewsItemId=CG59580&Transmission_Id=202508270700PR_NEWS_USPR_____CG59580&DateId=20250827